Akebia Therapeutics Inc.
AKBA | NASDAQ
$0.97
+$0.03 (+3.36%)
Sep 22, 2026, 12:20 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -29.67M | -20.51M | -5.35M | -15.91M | -36.48M | -45.31M | -69.41M | -45.99M | -40.44M | -43.69M | -51.93M | -60.09M | -97.47M | -57.27M | -93.48M | -156.6M | -164.28M | -275.68M | -282.84M | -299.16M | -299.58M | -392.29M |
Depreciation & Amortization | 1.55M | 1.28M | 1.27M | 10.29M | 19.35M | 28.44M | 37.5M | 37.56M | 37.6M | 37.59M | 37.63M | 37.64M | 37.66M | 37.68M | 37.7M | 37.73M | 37.79M | 37.87M | 37.97M | 36.24M | 33.38M | 33.49M |
Stock-Based Compensation | 13.31M | 12.76M | 11.28M | 9.78M | 8.21M | 7.6M | 7.78M | 7.59M | 7.77M | 9.19M | 9.32M | 10.84M | 12.38M | 15.8M | 17.85M | 19.44M | 21.68M | 21.28M | 22.74M | 24.19M | 25.19M | 25.54M |
Other Working Capital | 19.05M | 46.82M | 50.66M | 46.83M | 30.16M | 7.26M | -13.96M | -12.13M | -12.37M | -6.25M | -13.94M | -46.84M | -43.64M | -105.34M | -34.19M | -54.94M | -37.62M | 4.62M | -46.81M | -1.35M | -51.45M | -38.49M |
Other Non-Cash Items | 36.03M | 45.18M | 44.31M | 36.86M | 42.04M | 28.71M | 23.15M | 14.99M | 4.59M | 2.68M | 1.33M | -56.7M | -35.1M | -34.03M | -29.08M | 46.44M | 21.19M | 53.42M | 67.51M | 92.49M | 95.78M | 74.58M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 715K | 992K | 992K | 992K | 277K | n/a | n/a | 8.38M | 10.08M | 10.08M | 10.08M | 1.7M | 17M | 162.56M |
Change in Working Capital | 20.33M | 21.66M | 16.47M | -8.63M | -35.51M | -54.26M | -39.68M | -52.65M | -49.2M | -32.04M | -20.73M | -8.44M | 47.47M | -31.26M | -6.15M | -36.68M | -97.83M | -50.81M | -108.42M | -76.39M | -63.67M | 4.58M |
Operating Cash Flow | 41.55M | 60.37M | 67.99M | 32.4M | -2.4M | -34.81M | -40.66M | -38.5M | -38.97M | -25.28M | -23.38M | -75.76M | -34.78M | -69.07M | -73.15M | -81.28M | -171.36M | -203.84M | -252.97M | -220.94M | -191.91M | -91.55M |
Capital Expenditures | -1.38M | -427K | -383K | -223K | -148K | -51K | -33K | -31K | -29K | n/a | n/a | n/a | n/a | n/a | -114K | -114K | -114K | -114K | -59K | -376K | -421K | -466K |
Cash Acquisitions | 172K | 172K | 344K | 172K | 172K | 172K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -49.98M | -49.98M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20M | 40M | 100M | 100M | 80M |
Other Investing Acitivies | -10.89M | -7.89M | -7.89M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 90K | -49.86M |
Investing Cash Flow | -12.1M | -8.14M | -7.93M | -51K | 24K | 121K | -33K | -31K | -29K | n/a | n/a | n/a | n/a | n/a | -114K | -114K | -114K | 19.89M | 39.94M | 99.62M | 49.69M | -20.31M |
Debt Repayment | -14.35M | -5.99M | 4.63M | 9.54M | 9.54M | 17.17M | 7.9M | -100K | -100K | -15.73M | -32M | -24M | -57M | -49M | -33M | -33M | n/a | n/a | n/a | 19.98M | 19.98M | 19.98M |
Common Stock Repurchased | n/a | n/a | -63K | -63K | -63K | -63K | -750K | -750K | -750K | -750K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -540K | 961K | 1.44M | 1.44M | -40K | -40K | -381K | -380K | 142K | 142K | 1K | n/a | n/a | 67K | 40.07M | 40.07M | 40.07M | 40M | 44.78M | 44.78M | 45.19M | 45.6M |
Financial Cash Flow | -11.2M | -2.94M | 72.93M | 100.1M | 100.21M | 106.13M | 49.66M | 26.05M | 24.88M | 9.24M | -25.21M | -23.92M | -56.9M | -48.91M | 14.6M | 20M | 69.42M | 106.8M | 133.73M | 158.84M | 143.41M | 248.85M |
Net Cash Flow | 18.26M | 49.28M | 132.99M | 132.44M | 97.83M | 71.43M | 8.96M | -12.49M | -14.13M | -16.04M | -48.59M | -99.67M | -91.69M | -117.99M | -58.67M | -61.4M | -102.05M | -77.15M | -79.29M | 37.52M | 1.19M | 137M |
Free Cash Flow | 40.23M | 60.01M | 67.61M | 32.17M | -2.55M | -34.87M | -40.69M | -38.53M | -39M | -25.28M | -23.38M | -75.76M | -34.78M | -69.07M | -73.27M | -81.4M | -171.47M | -203.95M | -253.02M | -221.32M | -192.33M | -92.01M |
Adj. Free Cash Flow | 26.92M | 47.24M | 56.33M | 22.39M | -10.76M | -42.47M | -48.47M | -46.12M | -46.77M | -34.47M | -32.7M | -86.6M | -47.16M | -84.87M | -91.12M | -100.84M | -193.15M | -225.23M | -275.76M | -245.5M | -217.51M | -117.55M |
Maintenance CapEx | -647K | -62K | n/a | -2K | -4K | -33K | -33K | -31K | -29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -59K | -376K | -421K | -466K |
Growth CapEx | -733K | -365K | -383K | -221K | -144K | -18K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -114K | -114K | -114K | -114K | n/a | n/a | n/a | n/a |
Owner Earnings | 40.91M | 60.31M | 67.99M | 32.4M | -2.41M | -34.85M | -40.69M | -38.53M | -39M | -25.28M | -23.38M | -75.76M | -34.78M | -69.07M | -73.15M | -81.28M | -171.36M | -203.84M | -253.02M | -221.32M | -192.33M | -92.01M |
Add to Watchlist
Select watchlists to add or remove AKBA